Active lytic infection of human primary tonsillar B cells by KSHV and its noncytolytic control by activated CD4+ T cells
Jinjong Myoung, Don Ganem
Jinjong Myoung, Don Ganem
Published February 21, 2011
Citation Information: J Clin Invest. 2011;121(3):1130-1140. https://doi.org/10.1172/JCI43755.
View: Text | PDF
Research Article

Active lytic infection of human primary tonsillar B cells by KSHV and its noncytolytic control by activated CD4+ T cells

Abstract

Kaposi sarcoma–associated herpesvirus (KSHV) is a B-lymphotropic virus whose primary site of replication is the oropharynx. KSHV can infect both T and B cells from primary tonsillar explant cultures. However, T cells do not support lytic replication, while B cells spontaneously produce substantial amounts of infectious virus. Here, we provide evidence for a mechanism by which activated T cells may promote or stabilize latency of KSHV infection in B cells. When mixed cultures of B cells and activated T cells were exposed to KSHV, little spontaneous virus production was observed. Removing T cells from the mix or treating the mixed culture with immune suppressants enhanced virus production. Adding back activated T cells to purified infected B cells efficiently suppressed KSHV production, primarily due to CD4+ T cells. This suppressive activity required T cell activation and direct cell-cell contact, but not prior exposure to KSHV antigen. Suppression was not MHC restricted and did not result in killing of the target cell. We therefore propose that oropharyngeal T cells activated by a variety of stimuli can recognize ligands on infected target B cells, leading to signaling events that prevent spontaneous lytic activation and promote latent infection in this compartment.

Authors

Jinjong Myoung, Don Ganem

×

Figure 2

Viral gene expression in infected tonsillar cells.

Options: View larger image (or click on image) Download as PowerPoint
Viral gene expression in infected tonsillar cells. (A) Copy numbers of e...
(A) Copy numbers of eGFP, vCyclin, and ORF59 mRNA were determined by real-time quantitative PCR after gene-specific reverse transcriptase reactions on 50 ng of DNase-treated total RNA from fractionated T or B cells or unfractionated tonsillar cells (Mix) at the indicated time points; the cells were infected as described in Figure 1. Cells were treated with CsA for the indicated duration. Dots represent data from each individual tonsil. The mean of data from 6 different tonsils is indicated by the horizontal bar. **P < 0.01; ***P < 0.001 by Student’s t test. (B) Mixed cells or purified CD19+ B and CD3+ T cells were infected with rKSHV.219 as described in Figure 1 and Methods. At day 2 and day 4 after infection, total RNA was extracted and subjected to tiling microarray with linear amplification (for details, see Methods). –k, no viral infection. Total RNA from BCBL-1 cells, which were induced to lytic replication by Val (600 μM) for 1–3 days, was included as a positive control. KSHV tiling microarray data (ordered by genome position) are displayed for 13,444 unique probes. The color bar indicates the fold change relative to the level for the uninfected B cells. 2 independent experiments for B cells are shown. Array data for T and mixed cells are 1 representative of 2 independent experiments.